Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06586151 · ClinicalTrials.gov registry record · NA

Testing a Gender-inclusive HIV Prevention Program

A NA study of HIV Prevention, sponsored by Center for Innovative Public Health Research.

Recruiting
Registry status
NA
Development phase
200
Enrollment target
1
Study location

NCT06586151 is a NA study of HIV Prevention that is actively recruiting participants, run by Center for Innovative Public Health Research. The registered enrollment target is 200 participants, below the 376-participant average among 32 other HIV Prevention trials with a reported enrollment target (47% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06586151, a NA study of HIV Prevention, is actively recruiting participants, sponsored by Center for Innovative Public Health Research.

RECRUITING
Registry status
NA
Development phase
200 participants
Enrollment target
1
Study location

Study Summary

If, over time, data suggest the intervention impacts HIV preventive behavior at the population level, it will be unique in that it can be quickly and cost effectively scaled up to impact thousands of trans girls and nonbinary youth assigned male at birth.

Conditions Studied

Interventions

  • BEHAVIORAL Transcendent Health
  • BEHAVIORAL Text Messaging with Information

Study Locations (1)

California

  • Center for Innovative Public Health Research - San Clemente

Trial Details

FieldValue
Enrollment Target 200 participants
Start Date 2024-09-01
Est. Completion 2026-06-30
Phase NA

What the Registry Record Tells You About NCT06586151

The ClinicalTrials.gov registry entry for NCT06586151 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 200 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 376-participant average among 32 other HIV Prevention trials with a reported enrollment target (47% lower). The listed sponsor is Center for Innovative Public Health Research, which has 8 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Prevention appearing as the primary indexed condition, and to 2 interventions - of which Transcendent Health is the first listed.

NCT06586151 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT06586151 about?

NCT06586151 is a clinical study titled "Testing a Gender-inclusive HIV Prevention Program". If, over time, data suggest the intervention impacts HIV preventive behavior at the population level, it will be unique in that it can be quickly and cost effectively scaled up to impact thousands of trans girls and nonbinary youth assigned male at birth.

What is the current status of trial NCT06586151?

This trial is currently recruiting. It is a NA study. The enrollment target is 200 participants. The study started on 2024-09-01. Estimated completion is 2026-06-30.

What conditions does trial NCT06586151 study?

This clinical trial studies the following conditions: HIV Prevention.

What interventions are being tested in trial NCT06586151?

The interventions under investigation include: Transcendent Health (BEHAVIORAL), Text Messaging with Information (BEHAVIORAL).

Who is sponsoring clinical trial NCT06586151?

This trial is sponsored by Center for Innovative Public Health Research, which has 8 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06586151 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Prevention

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.